(90 days)
No
The description focuses on the physical characteristics and in vitro performance of a hollow fiber dialyzer, with no mention of AI or ML technologies.
Yes
The device is a hemodialyzer used to treat patients with acute or chronic renal failure, directly replacing a vital physiological function.
No
The device is a dialyzer used for treating renal failure, not for diagnosing medical conditions. It performs a therapeutic function (hemodialysis) by filtering blood.
No
The device description clearly details a physical medical device (hollow fiber dialyzer) with specific dimensions and materials, not a software-only product.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states that the device is used for hemodialysis in patients with acute or chronic renal failure. This is a treatment applied directly to the patient's blood within the device, not a test performed on a sample outside the body to diagnose a condition.
- Device Description: The description details the physical structure of the dialyzer and how blood flows through it for filtration. This is consistent with a therapeutic device, not a diagnostic one.
- Performance Studies: The performance studies focus on the device's ability to clear substances from the blood (urea, creatinine, phosphate, vitamin B12) and its ultrafiltration coefficient. These are measures of the device's therapeutic function, not its ability to detect or measure analytes for diagnostic purposes.
IVD devices are used to examine specimens derived from the human body (like blood, urine, tissue) to provide information for the diagnosis, monitoring, or treatment of a disease or condition. This device directly treats the patient's blood, making it a therapeutic device, not an IVD.
N/A
Intended Use / Indications for Use
The DYNAMIC Hollow Fiber Dialyzer DH-Series are indicated for use whenever a patient is in acute or chronic renal failure and hemodialysis is prescribed by a physician. Therefore, use of this device should be only on the direction of a physician who has evaluated all of the aspects of the patient's illness.
Product codes
78 FJI
Device Description
Blood enters a blood inlet port where it is distributed to hollow fibers. Each hollow fiber has an inner diameter of 200 microns and a wall thickness of 8 microns. The fibers used in this device which is substantially equivalent to the fibers utilized in the Focus R-Series Hollow Fiber Dialyzers (K914790) and Gambro GFS plus Series Hemodialyzer (K902481), which have been previously approved under a 510(k) Notification. The wall thickness of the hollow fibers in Focus R-Series Hollow Fiber Dialyzers and the proposed device is 8 microns. The inner diameter of hollow fibers in both Focus R-Series Hollow Fiber Dialyzers, Gambro GFS plus Series Hemodialyzer and the proposed device is 200 microns. The patient's blood traverses the inside of the hollow fibers and exits the device via a blood exit port.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
In vitro testing was performed on the proposed device to determine the following: urea, creatinine, phosphate, and vitamin B12 clearances, and ultrafiltration coefficient. The result indicates that the proposed device is substantially equivalent to Focus R-Series Hollow Fiber Dialyzers 120H-R(K914790) , Gambro GFS plus 20 Hemodialyzer (K902481), and DYNAMIC Hollow Fiber Dialyzer DC-Series (K973291) for in vitro performance.
Key Metrics
urea, creatinine, phosphate, and vitamin B12 clearances, and ultrafiltration coefficient.
Predicate Device(s)
Gambro GFS plus Series Hemodialyzer, DYNAMIC Hollow Fiber Dialyzer DC-series, K914790, K902481, K973291
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 876.5820 Hemodialysis system and accessories.
(a)
Identification. A hemodialysis system and accessories is a device that is used as an artificial kidney system for the treatment of patients with renal failure or toxemic conditions and that consists of an extracorporeal blood system, a conventional dialyzer, a dialysate delivery system, and accessories. Blood from a patient flows through the tubing of the extracorporeal blood system and accessories to the blood compartment of the dialyzer, then returns through further tubing of the extracorporeal blood system to the patient. The dialyzer has two compartments that are separated by a semipermeable membrane. While the blood is in the blood compartment, undesirable substances in the blood pass through the semipermeable membrane into the dialysate in the dialysate compartment. The dialysate delivery system controls and monitors the dialysate circulating through the dialysate compartment of the dialyzer.(1) The extracorporeal blood system and accessories consists of tubing, pumps, pressure monitors, air foam or bubble detectors, and alarms to keep blood moving safely from the blood access device and accessories for hemodialysis (§ 876.5540) to the blood compartment of the dialyzer and back to the patient.
(2) The conventional dialyzer allows a transfer of water and solutes between the blood and the dialysate through the semipermeable membrane. The semipermeable membrane of the conventional dialyzer has a sufficiently low permeability to water that an ultrafiltration controller is not required to prevent excessive loss of water from the patient's blood. This conventional dialyzer does not include hemodialyzers with the disposable inserts (Kiil type) (§ 876.5830) or dialyzers of high permeability (§ 876.5860).
(3) The dialysate delivery system consists of mechanisms that monitor and control the temperature, conductivity, flow rate, and pressure of the dialysate and circulates dialysate through the dialysate compartment of the dialyzer. The dialysate delivery system includes the dialysate concentrate for hemodialysis (liquid or powder) and alarms to indicate abnormal dialysate conditions. This dialysate delivery system does not include the sorbent regenerated dialysate delivery system for hemodialysis (§ 876.5600), the dialysate delivery system of the peritoneal dialysis system and accessories (§ 876.5630), or the controlled dialysate delivery system of the high permeability hemodialysis system § 876.5860).
(4) Remote accessories to the hemodialysis system include the unpowered dialysis chair without a scale, the powered dialysis chair without a scale, the dialyzer holder set, dialysis tie gun and ties, and hemodialysis start/stop tray.
(b)
Classification. (1) Class II (performance standards) for hemodialysis systems and all accessories directly associated with the extracorporeal blood system and the dialysate delivery system.(2) Class I for other accessories of the hemodialysis system remote from the extracorporeal blood system and the dialysate delivery system, such as the unpowered dialysis chair, hemodialysis start/stop tray, dialyzer holder set, and dialysis tie gun and ties. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.
0
Image /page/0/Picture/0 description: The image shows a handwritten date, "4/19/99". The numbers are written in black ink on a white background. The handwriting is somewhat stylized, with the numbers being tall and thin.
510(K) SUMMARY
SUBMITTER: Yaw C. Yang, Ph.D. 2F, 53, Park Ave. II, Science-Based Industrial Park. Hsinchu, Taiwan, R.O.C. Tel.: 886-3-578-9566 Fax: 886-3-579-9541
Jan./11/1999 DATE PREPARED:
DEVICE NAME : DYNAMIC Hollow Fiber Dialyzer DH-Series Focus R-Series Hollow Fiber Dialyzers PREDICATE DEVICE : Gambro GFS plus Series Hemodialyzer Dynamic Hollow Fiber Dialyzer DC-series
Device Description
Blood enters a blood inlet port where it is distributed to hollow fibers. Each hollow fiber has an inner diameter of 200 microns and a wall thickness of 8 microns. The fibers used in this device which is substantially equivalent to the fibers utilized in the Focus R-Series Hollow Fiber Dialyzers (K914790) and Gambro GFS plus Series Hemodialyzer (K902481), which have been previously approved under a 510(k) Notification. The wall thickness of the hollow fibers in Focus R-Series Hollow Fiber Dialyzers and the proposed device is 8 microns. The inner diameter of hollow fibers in both Focus R-Series Hollow Fiber Dialyzers, Gambro GFS plus Series Hemodialyzer and the proposed device is 200 microns. The patient's blood traverses the inside of the hollow fibers and exits the device via a blood exit port.
1
Page 2 of 3
Predicate Devices
The DYNAMIC Hollow Fiber Dialyzer DH-Series Dialyzers are substantially equivalent in construction, design, intended use, and function to other hemodialyzers currently marketed in the United States. The DYNAMIC Hollow Fiber Dialyzer DH-Series Dialyzers are substantially equivalent in function, design, and operation to the Focus R-Series Hollow Fiber Dialyzers , Gambro GFS plus Series Hemodialyzer, and DYNAMIC Hollow Fiber Dialyzer DC-Series(K973291), which have been previously approved for marketing in the United States under 510(K) Notifications.
Intended Use
The DYNAMIC Hollow Fiber Dialyzer DH-Series are indicated for use whenever a patient is in acute or chronic renal failure and hemodialysis is prescribed by a physician. Therefore, use of the device should be only on direction of a physician who has evaluated all of the aspects of the patient's illness. The indication statement is essentially the same as the indication statement of the predicate devices.
Technological Characteristics
Comparing the proposed device to the predicate devices, similarities are noted in the design and materials employed to accomplish the same intended use. All of the proposed device , Gambro GFS plus Series Hemodialyzer, and DYNAMIC Hollow Fiber Dialyzer DC-Series utilize polycarbonate for the header material and polyurethane for the membrane potting material. The proposed devices, Focus R-Series Hollow Fiber Dialyzers, and DYNAMIC Hollow Fiber Dialyzer DC-Series are sterilized by ethylene oxide gas.
In Vitro Performance
In vitro testing was performed on the proposed device to
2
K990159
determine the following: urea, creatinine, phosphate, and vitamin B12 clearances, and ultrafiltration coefficient. The result indicates that the proposed device is substantially equivalent to Focus R-Series Hollow Fiber Dialyzers 120H-R(K914790) , Gambro GFS plus 20 Hemodialyzer (K902481), and DYNAMIC Hollow Fiber Dialyzer DC-Series (K973291) for in vitro performance.
Conclusions
Testing performed on the DYNAMIC Hollow Fiber DH-Series indicated that it is safe, effective, and performs as well as the predicate devices, when used in accordance with the instructions for use.
3
Image /page/3/Picture/1 description: The image is a black and white seal for the Department of Health & Human Services - USA. The seal is circular with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized image of three curved lines that resemble a person.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
APR 1 9 1999
Yaw C. Yang, Ph.D. President & CEO DYNAMIC TECHNOLOGY CORP. 2F. No. 53. Park Ave. II Science-Based Industrial Park Hsinchu, TAIWAN, R.O.C.
Re: K990159 DYNAMIC Hollow Fiber Dialyzer DH-Series Dated: January 11, 1999 Received: January 19, 1999 Requiatory Class: II 21 CFR 876.5820/Procode: 78 FJI
Dear Dr. Yang:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Requilations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your labeling requlation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4613. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597, or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html".
Sincerely yours,
CAPT Daniel G. Schultz, M.D. Acting Director, Division of Reproductive, Abdominal, Ear, Nose and Throat, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
510(k) Number (if known): K990159
Device Name: DYNAMIC Hollow Fiber Dialyzer DH-Series
Indications for Use:
The DYNAMIC Hollow Fiber Dialyzer DH-Series are indicated for use whenever a patient is in acute or chronic renal failure and hemodialysis is prescribed by a physician. Therefore, use of this device should be only on the direction of a physician who has evaluated all of the aspects of the patient's illness.
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE NEEDED)
Concurrence of CDRH, Office Device Evaluation (ODE)
David L. Syam
(Division Sign-Off Division of Reproductive, Abdominal, ENT, and Radiological Devices 510(k) Number
Prescription Use
(Per 21 CFR 801.109)
OR
Over-The -Counter Use